Catalyst Pharmaceutical CPRX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's free cash flow yield?
- Catalyst Pharmaceutical (CPRX) reported free cash flow yield of 6.9% in Q1 2026.
- How has Catalyst Pharmaceutical's free cash flow yield changed year-over-year?
- Catalyst Pharmaceutical's free cash flow yield decreased by 24.2% year-over-year, from 9.1% to 6.9%.
- What is the long-term trend for Catalyst Pharmaceutical's free cash flow yield?
- Over 3 years (2021 to 2025), Catalyst Pharmaceutical's free cash flow yield has grown at a -5.1% compound annual growth rate (CAGR), from 8.5% to 7.3%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.